Bryce, it's a complicated question. Let me try to answer it as directly as I can. I'm pleased to share that at the moment, we have 7 mandates. I'll also caution you again that just because we have a mandate doesn't mean -- especially in the nonsponsor world, doesn't mean that when you do diligence that mandate, that it's a deal you'll close. But that is a nice group of mandated deals, and we always hope as many of those as possible will close. And if we get a majority of those to close, even before any more mandates that we're working on, that will allow us to have a significantly more deployment in the quarter than we had in Q3. Right now, if we were going to target 78% leverage, we have $80 million of capital to deploy, I want to deploy, if I can, the majority of that in Q4 and then the rest of it in Q1. The other thing, I guess, I'd share is, sort of, a follow-up question you could ask, but I'll get ahead of it. If we deployed that $80 million at a net return of 8.5% to 9.5% after leverage cost, which is very reasonable, given our historical deals, we've closed, that would be worth $0.08 to $0.09 per share per quarter, based on the math our team did. So while we did not earn our dividend this quarter, the cash and levers that we have available to us, once deployed, would imply that we should be able to earn our dividend on an annual basis. And hopefully, on a quarterly basis as much as possible. Does that answer your question, Bryce?